QC
STIM icon

Quadrature Capital’s Neuronetics STIM Stock Holding History

Quadrature Capital’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1K Buy
+30,856
New +$44.9K ﹤0.01% 1521
2025
Q4 		– Sell
-14,666
Closed -$40.2K – 1633
2025
Q3 		$40.2K Sell
14,666
-13,860
-49% -$49.2K ﹤0.01% 967
2025
Q2 		$99.3K Sell
28,526
-67,205
-70% -$265K ﹤0.01% 893
2025
Q1 		$351K Buy
+95,731
New +$349K 0.01% 688

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Quadrature Capital's STIM Position: Q2 2026 in Review

Quadrature Capital opened a new position in Neuronetics (STIM) in Q2 2026: 30,856 shares worth $40.1K. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in STIM as recently as Q3 2025.

Quadrature Capital first reported a position in STIM in Q1 2025 and has held it in 4 quarters since. The position peaked at $351K in Q1 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Quadrature Capital held 30,856 shares of Neuronetics worth $40.1K as of Q2 2026.
  • Neuronetics was a new Quadrature Capital position in Q2 2026.
  • Neuronetics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1521 holding.
  • Quadrature Capital first reported a position in Neuronetics in Q1 2025 and has held it in 4 quarters since.
  • Quadrature Capital's Neuronetics position peaked at $351K in Q1 2025.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.